For this reason, the activation of critical antioxidant pathways such as the Keap1/Nrf2 pathway have been show to repress the onset of T1D by protecting the β‐cells from the oxidative stress caused by inflammation [17]. The gene discussed is KEAP1; the disease is type 1 diabetes mellitus.